San Francisco-based Alix Ventures is a venture capital fund that supports early-stage life science startups. Its mission is to partner with passionate and accomplished founders who possess unique insights to solve some of the world’s most daring problems facing us in life sciences.
With the rise of TechBio, the fund believes life sciences is experiencing rapid innovation that leads to some of the most impactful solutions in decades. Alix Ventures aims to help build transformative companies ahead of this revolution to significantly impact the quality and effectiveness of patient care.
The Team: Serial VC-Backed Life Sciences Founders with Hands-On Experience
Alix Ventures’ team is composed of serial VC-backed life sciences founders with hands-on experience in raising capital, scaling teams, running labs, navigating regulatory mazes, and partnering with pharma. The team’s extensive experience in operating early-stage companies has allowed them to curate a full platform of resources to help their portfolio companies with customer introductions, fundraising, team building, and more.
Scientific and Medical Advisory Board (SAB/MAB)
Composed of top VC-backed PhD life sciences founders, Alix Ventures’ scientific and medical advisory board provides technical and clinical diligence expertise across a wide variety of life science sub-domains. Alix Ventures aims to partner with founders who possess unique insights into solving some of the world’s most daring problems in life sciences.
Support for Founders
Helping founders is Alix Ventures’ utmost priority, and to tackle the many challenges ahead, the fund has curated a full platform of resources. In addition, Alix Ventures has a dedicated operating partner, Mark Pulido, who has experience as a five-time HC/LS CEO, previously with Novartis, McKesson, and Ability. The fund also has an extensive network of industry executives spanning Top 25 Pharma, major health systems, and large payors.
Limited Partners (LPs)
Alix Ventures is anchored by leading strategic LPs, including some of the best venture capital firms in the world, veteran founders, and industry experts. The fund is here to fill the void for early-stage life sciences specific capital in Silicon Valley.
Alix Ventures: Driving Patient Impact
In conclusion, Alix Ventures is a venture capital fund that supports early-stage life science startups engineering biology to drive radical advances in human health. Its team’s hands-on experience, scientific and medical advisory board’s expertise, and platform of resources to help founders make the fund an ideal partner for those passionate about transforming healthcare. With its mission to fill the void for early-stage life sciences specific capital in Silicon Valley, Alix Ventures is poised to drive patient impact by partnering with transformative companies that possess unique insights into solving some of the world’s most daring problems in life sciences.
Ready to Promote Your Brand with Finance Magazine?
Looking to reach a targeted audience of finance professionals and decision-makers? Finance Magazine offers sponsored article opportunities and partnerships to help you showcase your brand and drive sales. Learn more about our advertising options and reach out to us today! Click here to discuss sponsored articles and partnerships.
Maximize your brand visibility and engage with a highly engaged finance audience. Contact us at [email protected] to get started. Let Finance Magazine be your platform for success!